COMIRNATY 10 microgrammes/dose, dispersion à diluer pour dispersion injectable.Vaccin à ARNm (à nucléoside modifié) contre la COVID-19 — 10 flacon(s) multidose(s) en verre de 10 dose(s) ( abrogée le 12/12/2024)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930243404 -
CIP7
3024340 -
CIS
69174918 -
Registration number
EU/1/20/1528
What the source publishes
- Holder
- BIONTECH MANUFACTURING (ALLEMAGNE)
- Active ingredients
- TOZINAMÉRAN
- Form
- dispersion à diluer pour dispersion injectable
- Package
- 10 flacon(s) multidose(s) en verre de 10 dose(s) ( abrogée le 12/12/2024)
- Routes
- intramusculaire
- Administrative status
- cancelled
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2021-11-26
- Prescription
- Prescription or restricted
Names this record is found by
- COMIRNATY 10 microgrammes/dose, dispersion à diluer pour dispersion injectable.Vaccin à ARNm (à nucléoside modifié) contre la COVID-19 — 10 flacon(s) multidose(s) en verre de 10 dose(s) ( abrogée le 12/12/2024)
- COMIRNATY 10 microgrammes/dose, dispersion à diluer pour dispersion injectable.Vaccin à ARNm (à nucléoside modifié) contre la COVID-19
- TOZINAMÉRAN
Complete source data
{
"cis": "69174918",
"cip7": "3024340",
"form": "dispersion à diluer pour dispersion injectable",
"name": "COMIRNATY 10 microgrammes/dose, dispersion à diluer pour dispersion injectable.Vaccin à ARNm (à nucléoside modifié) contre la COVID-19 — 10 flacon(s) multidose(s) en verre de 10 dose(s) ( abrogée le 12/12/2024)",
"cip13": "3400930243404",
"holder": "BIONTECH MANUFACTURING (ALLEMAGNE)",
"routes": [
"intramusculaire"
],
"holders": [
"BIONTECH MANUFACTURING (ALLEMAGNE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": "Warning disponibilité",
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2021-11-26",
"compositions": [
{
"name": "TOZINAMÉRAN",
"nature": "SA",
"strength": "10 microgrammes",
"linkageNumber": "1",
"substanceCode": "34560",
"dosageReference": "une dose de 0,2 mL après dilution (un flacon contient 10 doses après dilution)",
"pharmaceuticalElement": "dispersion"
}
],
"sourceStatus": "Présentation abrogée",
"supplyRegime": "liste I",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "COMIRNATY 10 microgrammes/dose, dispersion à diluer pour dispersion injectable.Vaccin à ARNm (à nucléoside modifié) contre la COVID-19",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "10 flacon(s) multidose(s) en verre de 10 dose(s) ( abrogée le 12/12/2024)",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2021-12-14",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": true,
"administrativeStatus": "cancelled",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"TOZINAMÉRAN"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation abrogée",
"europeanAuthorisationNumber": "EU/1/20/1528",
"presentationAdministrativeStatus": "cancelled"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930243404"